Ivan Dimov net worth
Quick answer
Ivan Dimov's estimated net worth is $75.0M (range $52.5M – $112.5M) as of 2026. Ivan Dimov is CEO at Lucira Health. Lucira Health valuation.
Ivan Dimov is CEO at Lucira Health (YC W15). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Public
- Background: Bulgarian
- Education: PhD in Applied Biophysics from Dublin City University; Bachelor's and Master's degrees in Electronics, Telecommunications, and Computer Science from Universidad Técnica Federico Santa María, Chile.
- Region: United States of America
- Industries: Healthcare, Diagnostics
- Team size: 43
- Website: https://www.lucirahealth.com/
Who is Ivan Dimov?
Ivan Dimov is a co-founder of Lucira Health, a molecular diagnostics company, and currently serves as the CEO and co-founder of Orca Bio, which develops high-precision cell therapies.
Highlights:
- Co-founder of Lucira Health (YC W15 batch)
- Co-founder and CEO of Orca Bio
- Siebel Fellow and Visiting Instructor at Stanford University
Background
Ivan Dimov was born in Bulgaria. Heritage/background labels may be inferred and are not verified identity documents.
About Lucira Health
Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in...
FAQ: Ivan Dimov net worth and Lucira Health valuation
What is Ivan Dimov's net worth?
Ivan Dimov's estimated net worth is $75.0M (range $52.5M – $112.5M) as of 2026. Ivan Dimov is CEO at Lucira Health. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Lucira Health valuation?
Lucira Health's estimated valuation on Entrepreneurial Check is $2.0B. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Ivan Dimov's role?
Ivan Dimov is CEO at Lucira Health, a Y Combinator-backed startup (batch W15).